Information:

Dorzy Drop Dorzy Drop contains dorzolamide hydrochloride , an inhibitor of human carbonic anhydrase. Following topical administration, DORZY reduces elevated intraocular pressure. Elevated intraocular a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual loss.

Dorzy Drop contains dorzolamide hydrochloride , an inhibitor of human carbonic anhydrase. Following topical administration, DORZY reduces elevated intraocular pressure. Elevated intraocular a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual loss. | Key Ingredients: Dorzolamide Hydrochloride Equivalent to Dorzolamide Benzalkonium Cholride Solution Sterile Aqueous Vehicle | Key Benefits: It contains dorzolamide hydrochloride , an inhibitor of human carbonic anhydrase. It reduces elevated intraocular pressure. Helpful in pathogenesis of optic nerve damage and glaucomatous visual loss. | Directions for use: One drop of DORZY is to be instilled in affected eye three times daily It may be used concomitantly with other topical ophthalmic solution drug products to lower intraocular pressure If more than one ophthalmic drug is being used, the drugs should be administered at least ten minutes apart | Safety Information: Read the label carefully before use Store in a cool and dry place, away from sunlight Keep out of the reach of children

Product Highlights:

Key Ingredients:

Key Benefits:

Indications:

Dorzolamide Hydrochloride | Equivalent to Dorzolamide | Benzalkonium Cholride Solution | Sterile Aqueou Vehicle

Product Form:

Candor Biotech Ltd

Directions For Use:

Safety Information:

Read the label carefully before use | Store in a cool and dry place, away from sunlight | Keep out of the reach of children